- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05204914
Effect Of Supraglottic Airway Devices On The Tempromandibular Joint Function Following Prolonged General Anesthesia
Study Overview
Status
Intervention / Treatment
Detailed Description
Supraglottic airway devices (SADs) are used for securing the airway in over 50% of general anesthetics; They are used for both spontaneously & ventilated patients; They also used as conduits to aid endotracheal intubation when both positive mechanical ventilation ( PMV) & tradional endotracheal intubation( ETT) have failed
All (SADs) consist of a tube that connected to a breathing circuit or a breathing bag which is attached to a hypopharengeal device that seals air flow to the glottis
There are many types of SADs including I-Gel, intubating laryngeal mask airway (LMA), LMA CTrash and LMA proseal Although considered relatively safe devices; and have many advantages as they are less invasive than EET, less incidence of bronchospasm, don't often require muscle relaxation or neck mobility
There are several potential complications & disadvantages ; Include temporomandibular joint (TMJ) dysfunction, increases the risk of aspiration, more gas leak &pollution, less safe in prone postion & deeper anaethesia is required
This study will investigate (TMJ) dysfunction following the use of a (SAD) during general anesthesia, as There are a number of insertion maneuvers described for (SADs) [2] such as a jaw thrust may result in temporomandibular joint (TMJ) dysfunction by anteriorly displacing the mandible . In addition, other factors such as degree of muscle relaxation leading to hypotonicity of jaw muscles and passive mouth opening. In addition, for the duration of the operation the mouth is kept slightly open by a breathing tube may result in (TMJ) dislocation.
The inter-incisor distance will be measured using a Therabite â ruler (ATOS Medical, Nottingham, UK). This has a scale from 0 to 70 mm with 1-mm markings. The accuracy of this type of ruler is1.0 mm. The Therabite ruler was chosen as it routinely used by the investigators for (TMJ) assessment in the maxillofacial clinic.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion The study will include 60 adult patients (>18 years old) with ASA physical status class I and class II scheduled for elective surgery under general anesthesia where SADs ara planned to be used as airway devices
Exclusion Criteria:
- Patient refusal
- limited mouth opening(<2 fingers)
- Facial &upper airway trauma
- Patients with dentures or who were edentulous (as accurate objective measurements would be difficult to determine)
- Head and neck surgery (as surgery may influence TMJ function)
- GITsurgery (as SAD doesn't completely protect air way against aspiration )
- Pt with preexisting tempromadibular joint dysfunction
- Duration of anaethesia less than 1 h or more than 4hs-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Supra glottic airway devices
|
Using the device in save air way in patients under general anesthesia and the change in the tempromandibular joint will be evaluated
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in tempromandibular jiont function
Time Frame: Single measurement Within 24 hours postoperative
|
The change in inter incisors distance,forword movement&lat movement of the jow post operative will be measured also any post op pain or difficulty in movement of the jow will be recorded
|
Single measurement Within 24 hours postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Other complications of supraglottic airway devices
Time Frame: Intra operative &24hours postoperative
|
Including aspiration and airway edema
|
Intra operative &24hours postoperative
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Soh-med-21-10-05
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Supra glottic airway devices
-
Kasr El Aini HospitalCompleted
-
Cairo UniversityUnknownSupraglottic Airway DevicesEgypt
-
Rutgers, The State University of New JerseyTerminatedTopical Eucalyptus Globulus and Mentha x Piperita on Muscle Soreness in Older Adults and the ElderlyMuscle SorenessUnited States
-
University Hospital of PatrasRecruiting
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterCompletedObesity | Hypoxia | Obstructive Sleep ApnoeaUnited Kingdom
-
Karolinska InstitutetGöteborg University; University of Padova; Hanoi Obstetrics and Gynecology HospitalRecruitingRespiratory Distress Syndrome in Premature InfantVietnam
-
University Hospital, AntwerpNot yet recruitingObstructive Sleep Apnea | Cardiovascular (CV) Risk
-
Karolinska InstitutetGöteborg University; Hanoi Medical University; Hanoi Obstetrics and Gynecology...CompletedRespiratory Distress Syndrome, NewbornVietnam
-
Konya City HospitalRecruitingMechanical PowerTurkey (Türkiye)
-
Marya Strand, MDCompletedRespiratory Distress SyndromeUnited States